Date: 28 February 2010, 02:50
|
Date: 28 February 2010, 02:49
|
Date: 28 February 2010, 02:47
|
Date: 28 February 2010, 02:45
|
Date: 28 February 2010, 02:42
|
Over 6,000 people piled into the Westin St. Francis Hotel in San Francisco for J.P. Morgan’s (JPM) “28th Annual Healthcare Conference.” Investors, company presenters, and entrepreneurs were emboldened by good biotech sector returns in 2009 of 18–28% with many stocks reaching new highs. Seasonality has been a factor with the so-called “January effect,” where small-cap stocks tend to spike for a number of reasons, this conference paramount among them. For example, the IBB ETF is up about 6% from November levels. Following are some brief notes from important companies presenting at JPM. Date: 17 January 2010, 22:49
|
At the 28th annual JP Morgan Healthcare conference, which ran from January 11- January 14th 2010, there were more than 300 companies represented, making their presentations to more than 6000 public and private equity and venture capital investors. There was considerable enthusiasm for the sector this past week; it seemed like every biotech company rallied and closed the week up. But what will happen after the JP Morgan Healthcare Conference? Was the activity the last couple weeks just due to short term investor enthusiasm? Date: 17 January 2010, 22:19
|
One of the best performing European biotech companies in 2009 was Swedish biotech company Active Biotech. With a performance of more than 200% the stock was one of the top 3 best performing Biotech companies. And also in 2010 the company seems to continue its winning streak with a YTD performance of already 35%. What is the story behind this amazing performance. Date: 10 January 2010, 20:06
|
They say aging is one of the few certain things in life. But it turns out that they were wrong. In recent years gerontologists have overturned much of the conventional wisdom about getting old. Aging is not the simple result of the passage of time. According to a provocative new view, it is actually something our own bodies create, a side effect of the essential inflammatory system that protects us against infectious disease. As we fight off invaders, we inflict massive collateral damage on ourselves, poisoning our own organs and breaking down our own tissues. We are our own worst enemy. Date: 22 October 2009, 22:38
|
A video showing what to expect from the Swine Flu and what companies will profit Date: 14 September 2009, 02:07
|